M.NacciC.DeckerP.AndriantsitohainaR.MullerS.et al (1999)
Future concerns These results offer a fascinating snapshot of how multipurpose weight loss drugs like GLP-1 agonists could open up new avenues to mental health treatment
Recent, as yet fragmentary evidence suggests that intervention with GLP1-RA, e.g., liraglutide, may reduce body weight and improve hyperandrogenism and menstrual irregularities in women with obesity and PCOS 28,29,30,31,32
Busse*, Nizar Jarjour, Ronald Sorkness, Sean Fain, and Gina Crisafi
Dhillon S (2021) Melphalan flufenamide (Melflufen): first approval
The weight loss guarantee adds a layer of accountability that most telehealth platforms avoid it signals confidence in the program and provides patients with a safety net